Clinical value of combined CA125 and EMAb in adenomyosis
article
OA: closed
CC0
Abstract
Objective:To discuss the clinical value of combined CAI25 and EMAb in adenomysis.Methods: Examined serum CAI25 concentration and EMAb expression in 179 adenomysis and 129 hysteromyoma patients.Results:Compared with hysteromyoma patients,the level of CAI25 and the positive rat of EMAb in adenomysis were statistically raised(P0.001,P0.01).Combined CA125 and EMAb,the sensitivity and specialty were 51.04% and 100% in adenomysis patients.Conclusion:It is greatly useful to combine CA 125 and EMAb in adenomysis patients.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK